CD5


Also found in: Wikipedia.

CD5

a type I transmembrane protein found on T cells, thymocytes, and some B cells that is a ligand for CD72 and is involved in cellular activation or adhesion; expressed in B-cell chronic lymphocytic leukemia and T-cell lymphoma.
References in periodicals archive ?
(TMA), the U.S.-based subsidiary of Toshiba Memory Corporation, has unveiled that its CD5 Series data center NVMe SSDs and CM5 Series enterprise NVMe SSDs are now certified to operate with the DriveScale Composable Platform.
PT ran a data analytics workload on HPE ProLiant Gen10 servers configured with three different kinds of solid-state drives: Toshiba Memory RM5 Series value SAS and CD5 Series data center NVMe[TM] SSDs, and enterprise SATA SSDs.
An automated Ventana Benchmark-XT platform (Ventana System, Tucson, Arizona) with the iView Detection Kit was used for the staining with CD3 (predilute; clone LN10, Leica, Wetzlar, Germany), CD5 (1:40; clone 4C7, Leica), CD20 (1:800; clone L26, Dako, Carpinteria, California), immunoglobulin (Ig) M (1:1000; rabbit polyclonal, Dako), IgG (1:10,000; rabbit polyclonal, Dako), IgA (1:1000; rabbit polyclonal, Dako), and Ki-67 (prediluted; clone 30-9, Ventana, Oro Valley, Arizona).
However, without the infrastructure built during the development of ConocoPhillips Alaska's CD5 site, which provides capacity to run everything back to the Alpine processing facility, GMT1 would have never gotten off the ground.
Those lymphoma cells expressed diffuse positive immunohistochemical stain for CD20, CD79a, CD5, and cyclin D1, but were negative for CD10, CD23, BCL6, and MUM1.
The HART AKI test algorithmically interprets six clinical and protein variables (history of diabetes, blood urea nitrogen to creatinine ratio, C-reactive protein, osteopontin, CD5 antigen-like, and Factor VII).
Atypical cells CD2, CD3, CD5, CD7, and TIA1 were found positive, CD20, CD79a, and CD117 were found negative, and MPO myeloid cells were positive.
monoclonal antibody against human cd5, apc-conjugated 1 fl.
The cells are strongly immunoreactive for pan B-Cell markers CD19 and CD20, and for CD23 and CD5 also.
In the immunohistochemical analysis, the tumor cells were positive for LCA, CD3, CD7, CD8, and CD56, and negative for CD20, CD5, CD4, CD79a, CD10, CD99, and CK.
These mature pDCs show largely the same immunoprofile as their reactive counterparts, CD123, BDCA2, and TCL1 positive, but occasionally aberrantly express CD2, CD5, CD7, CD10, CD13, CD14, CD15, and CD33.
A few scattered T cells were positive for CD3, CD5, and Bcl-2.